0,865  0,004  Caspase 9 stimulant
0,844  0,003  UGT1A9 substrate
0,827  0,007  TNF expression inhibitor
0,824  0,014  Apoptosis agonist
0,769  0,004  CTGF expression inhibitor
0,762  0,008  15-Lipoxygenase inhibitor
0,762  0,013  Antineoplastic (breast cancer)
0,748  0,005  NOS2 expression inhibitor
0,748  0,013  Antineoplastic (lung cancer)
0,737  0,005  Lipoxygenase inhibitor
0,734  0,005  Cardiovascular analeptic
0,701  0,005  UGT1A1 substrate
0,684  0,004  Monophenol monooxygenase inhibitor
0,682  0,004  Skin whitener
0,676  0,007  Antioxidant
0,667  0,007  Caspase 3 stimulant
0,677  0,023  Transcription factor NF kappa B inhibitor
0,656  0,005  Genotoxic
0,648  0,006  Free radical scavenger
0,653  0,018  Antileukemic
0,640  0,010  12-Lipoxygenase inhibitor
0,638  0,014  Aldehyde oxidase inhibitor
0,635  0,012  Sensitization
0,661  0,038  Antiinflammatory
0,636  0,014  Chemoprotective
0,631  0,020  Antineoplastic (colorectal cancer)
0,618  0,009  AR expression inhibitor
0,615  0,007  Antimutagenic
0,626  0,020  Antineoplastic (colon cancer)
0,606  0,003  Neurotrophic factor enhancer
0,620  0,021  GST A substrate
0,609  0,016  Antihypercholesterolemic
0,589  0,010  Antineoplastic (brain cancer)
0,594  0,015  Radioprotector
0,585  0,014  Antineoplastic (melanoma)
0,577  0,009  UGT1A6 substrate
0,574  0,010  Antiprotozoal (Leishmania)
0,560  0,003  Coagulant
0,572  0,015  Chemopreventive
0,577  0,021  Prostate cancer treatment
0,560  0,005  Melanin inhibitor
0,576  0,022  Antiprotozoal
0,576  0,023  Antibacterial
0,560  0,011  Antineoplastic (glioma)
0,553  0,017  Antineoplastic (cervical cancer)
0,555  0,020  Antineoplastic (ovarian cancer)
0,546  0,013  Antineoplastic (multiple myeloma)
0,518  0,003  SULT1A3 substrate
0,520  0,009  Antihypertriglyceridemic
0,524  0,020  GABA C receptor rho-3 antagonist
0,513  0,016  Antineoplastic (non-small cell lung cancer)
0,499  0,005  Lipid peroxidase inhibitor
0,503  0,011  Antineoplastic enhancer
0,514  0,022  Carcinogenic
0,505  0,013  Antineoplastic (glioblastoma multiforme)
0,514  0,024  Histamine release inhibitor
0,497  0,007  UGT1A3 substrate
0,512  0,023  Antiprotozoal (Plasmodium)
0,509  0,020  Antineoplastic (pancreatic cancer)
0,515  0,027  Antithrombotic
0,498  0,012  UDP-glucuronosyltransferase substrate
0,485  0,004  Electron transport complex I inhibitor
0,485  0,009  Antiulcerative
0,497  0,021  Mutagenic
0,480  0,005  5-Lipoxygenase inhibitor
0,495  0,021  Cytostatic
0,489  0,017  Nitric oxide antagonist
0,478  0,012  Antihypoxic
0,473  0,008  Antineoplastic (squamous cell carcinoma)
0,492  0,029  CYP2C19 substrate
0,473  0,012  Antineoplastic (renal cancer)
0,455  0,009  Dual specificity phosphatase inhibitor
0,463  0,019  Hypoglycemic
0,469  0,029  Cytotoxic
0,455  0,016  Eye irritation, high
0,466  0,028  Antifungal
0,475  0,038  Calcium channel L-type activator
0,467  0,032  Ulceration
0,447  0,014  RNA-directed DNA polymerase inhibitor
0,448  0,015  Antineoplastic (osteosarcoma)
0,457  0,026  Apoptosis antagonist
0,461  0,035  Embryotoxic
0,453  0,028  Lipoprotein disorders treatment
0,434  0,010  Antiseptic
0,440  0,017  Radiosensitizer
0,429  0,009  UGT2B7 substrate
0,440  0,024  Proliferative diseases treatment
0,453  0,038  Teratogen
0,454  0,040  Cholesterol antagonist
0,423  0,012  Antineoplastic (carcinoma)
0,414  0,009  Topoisomerase II inhibitor
0,434  0,032  Antimycobacterial
0,406  0,007  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,416  0,019  Myocardial infarction treatment
0,421  0,024  Antiprotozoal (Trypanosoma)
0,408  0,014  UGT1A4 substrate
0,409  0,017  Transcription factor STAT3 inhibitor
0,407  0,015  P-glycoprotein inhibitor
0,417  0,026  Hypoxia-inducible factor 1 alpha inhibitor
0,407  0,018  Transcription factor STAT inhibitor
0,413  0,024  Antineoplastic (lymphoma)
0,410  0,023  Antiparasitic
0,419  0,033  Antiosteoporotic
0,394  0,009  Protein-tyrosine phosphatase inhibitor
0,395  0,011  Mcl-1 antagonist
0,402  0,019  Antineoplastic (small cell lung cancer)
0,391  0,009  Tyrosine 3 hydroxylase inhibitor
0,420  0,039  FMO1 substrate
0,388  0,009  Protein kinase stimulant
0,406  0,029  UGT2B4 substrate
0,393  0,017  Antihelmintic
0,419  0,044  Bone diseases treatment
0,381  0,007  Glutathione S-transferase substrate
0,423  0,051  CYP2C19 inhibitor
0,374  0,005  Cystathionine beta-synthase inhibitor
0,421  0,056  Immunosuppressant
0,401  0,038  Cardioprotectant
0,407  0,044  5 Hydroxytryptamine release stimulant
0,385  0,026  Antineoplastic (liver cancer)
0,399  0,040  ICAM1 expression inhibitor
0,381  0,029  Hypolipemic
0,357  0,005  Neurotrophic factor
0,384  0,036  Antituberculosic
0,352  0,006  Antihemorrhagic
0,388  0,042  Spasmolytic
0,373  0,028  Vasodilator
0,356  0,011  UGT2B15 substrate
0,375  0,031  Superoxide dismutase inhibitor
0,360  0,019  Skin irritative effect
0,345  0,004  Farnesoid X receptor antagonist
0,353  0,013  Amylase inhibitor
0,357  0,024  Abortion inducer
0,339  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,378  0,049  CYP2D6 substrate
0,396  0,068  Antipruritic, allergic
0,331  0,004  SULT1A1 substrate
0,337  0,011  CYP2B6 inhibitor
0,425  0,104  Alpha-glucosidase inhibitor
0,353  0,034  Amyloid beta aggregation inhibitor
0,344  0,025  GST M1-1 substrate
0,366  0,048  NOS3 expression inhibitor
0,351  0,037  Cardiodepressant
0,319  0,006  Antibacterial (Helicobacter pylori)
0,394  0,082  5 Hydroxytryptamine release inhibitor
0,378  0,068  CYP2C9 inhibitor
0,337  0,030  Peroxidase inhibitor
0,316  0,015  GST P1-1 substrate
0,367  0,067  Vasodilator, peripheral
0,355  0,054  Respiratory analeptic
0,336  0,040  Antidiabetic symptomatic
0,389  0,097  Cyclophilin D inhibitor
0,389  0,097  Antidiabetic
0,298  0,007  Topoisomerase II alpha inhibitor
0,323  0,036  Antineoplastic (lymphocytic leukemia)
0,297  0,012  Cholesterol synthesis inhibitor
0,311  0,027  Hepatoprotectant
0,328  0,049  CYP1A2 inhibitor
0,314  0,036  Antineoplastic (sarcoma)
0,290  0,015  Phospholipase A2 inhibitor
0,286  0,012  UGT2B9 substrate
0,322  0,051  Antineoplastic (endocrine cancer)
0,297  0,026  VCAM1 expression inhibitor
0,299  0,029  Dual specificity phosphatase 3 inhibitor
0,299  0,030  Antihypotensive
0,308  0,041  DNA synthesis inhibitor
0,311  0,045  Vascular (periferal) disease treatment
0,346  0,080  Stroke treatment
0,269  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,317  0,053  FMO3 substrate
0,283  0,021  Tubulin antagonist
0,265  0,004  CDC25A inhibitor
0,295  0,036  Gastrin inhibitor
0,271  0,014  DNA polymerase I inhibitor
0,303  0,048  Antiglaucomic
0,277  0,024  Interferon gamma antagonist
0,260  0,013  Antineoplastic antibiotic
0,320  0,073  Immunostimulant
0,261  0,017  LDLR expression enhancer
0,310  0,069  Analeptic
0,267  0,026  Insulin sensitizer
0,253  0,012  UGT2B10 substrate
0,326  0,091  CYP2C9 substrate
0,241  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,254  0,020  NADPH oxidase inhibitor
0,250  0,018  Aldehyde dehydrogenase inhibitor
0,237  0,006  TRPA1 agonist
0,238  0,007  HIV-1 integrase (3'-Processing) inhibitor
0,260  0,030  Antiviral (Herpes)
0,286  0,057  Antiamyloidogenic
0,231  0,004  CDC25B inhibitor
0,239  0,014  Sulfotransferase substrate
0,245  0,022  Heat shock protein 90 antagonist
0,233  0,010  Arachidonic acid antagonist
0,239  0,018  Chelator
0,305  0,083  Vasodilator, coronary
0,252  0,031  Antihelmintic (Nematodes)
0,301  0,081  Hepatic disorders treatment
0,299  0,079  Streptokinase A inhibitor
0,276  0,059  Angiogenesis stimulant
0,276  0,059  5 Hydroxytryptamine uptake stimulant
0,353  0,137  Antineoplastic (solid tumors)
0,239  0,027  Bone formation stimulant
0,219  0,008  Vanilloid 1 agonist
0,276  0,067  DNA damaging
0,224  0,018  Antirickettsial
0,210  0,005  DOPA decarboxylase inhibitor
0,240  0,036  Thrombolytic
0,226  0,023  Antifungal enhancer
0,252  0,050  Peptidyltransferase inhibitor
0,224  0,025  MAO A inhibitor
0,218  0,018  Interleukin 4 antagonist
0,231  0,032  MAO inhibitor
0,223  0,024  Antiprotozoal (Coccidial)
0,240  0,045  Pneumotoxic
0,262  0,069  Tumour necrosis factor alpha release inhibitor
0,225  0,032  Succinate dehydrogenase inhibitor
0,290  0,102  Calcium channel activator
0,226  0,037  Antineoplastic (gastric cancer)
0,197  0,011  Creatine kinase inhibitor
0,221  0,036  Antiacne
0,193  0,009  Thioredoxin inhibitor
0,205  0,025  Topoisomerase I inhibitor
0,194  0,014  Photosensitizer
0,224  0,044  Growth factor agonist
0,192  0,013  HIV-1 integrase (Overall Integration) inhibitor
0,240  0,061  Antiviral (HIV)
0,193  0,015  Antiinfertility, female
0,184  0,007  Lipase inhibitor
0,208  0,031  Acetylcholinesterase inhibitor
0,181  0,005  Ornithine decarboxylase inhibitor
0,195  0,021  Movement disorders treatment
0,189  0,015  Breast cancer-resistant protein inhibitor
0,189  0,018  UGT2B1 substrate
0,173  0,004  SULT1A2 substrate
0,175  0,007  TRPA1 antagonist
0,226  0,059  Wound healing agent
0,171  0,006  Thioredoxin reductase inhibitor
0,174  0,010  Ca2+-transporting ATPase inhibitor
0,172  0,011  Antiprotozoal (Toxoplasma)
0,193  0,033  GABA C receptor rho-2 antagonist
0,165  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,197  0,037  Insulin secretagoues
0,212  0,053  Antipruritic, non-allergic
0,165  0,007  Leukotriene synthesis inhibitor
0,194  0,037  Cyclooxygenase 1 inhibitor
0,241  0,087  Antineoplastic (bladder cancer)
0,168  0,014  NAD(P)H dehydrogenase (quinone) inhibitor
0,180  0,026  Adenylate cyclase stimulant
0,204  0,050  Antianorexic
0,185  0,031  Toll-Like receptor 2 antagonist
0,179  0,026  Microtubule formation inhibitor
0,163  0,012  Anabolic
0,161  0,010  Estrogen receptor alpha antagonist
0,194  0,043  NOS3 expression enhancer
0,214  0,064  Platelet adhesion inhibitor
0,167  0,019  Antispirochetal
0,171  0,024  Alcohol dehydrogenase substrate
0,165  0,019  Beta glucuronidase inhibitor
0,175  0,030  Cyclooxygenase 3 inhibitor
0,231  0,087  Antipyretic
0,244  0,104  CYP1A2 substrate
0,154  0,014  Keratolytic
0,160  0,020  Estrogen antagonist
0,159  0,020  Cathepsin G inhibitor
0,153  0,014  UGT2B11 substrate
0,177  0,042  Cell wall synthesis inhibitor
0,202  0,069  Non-steroidal antiinflammatory agent
0,154  0,021  Prolactin inhibitor
0,144  0,011  Vanilloid agonist
0,169  0,037  Alkylator
0,151  0,020  Porphobilinogen synthase inhibitor
0,174  0,043  CF transmembrane conductance regulator agonist
0,185  0,055  Antineoplastic (bone cancer)
0,143  0,014  Aromatase inhibitor
0,141  0,012  Phosphodiesterase 6D inhibitor
0,132  0,005  Potassium channel Kv1.3 blocker
0,158  0,031  GABA C receptor agonist
0,132  0,005  Antimycoplasmal
0,141  0,015  Peroxisome proliferator-activated receptor gamma agonist
0,179  0,053  Uterine stimulant
0,160  0,034  Carcinogenic, group 2B
0,216  0,091  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,251  0,127  Sodium/bile acid cotransporter inhibitor
0,135  0,011  Bile acid receptor antagonist
0,180  0,056  Acaricide
0,138  0,017  Antiviral (Rhinovirus)
0,203  0,082  Antimitotic
0,149  0,029  Mediator release inhibitor
0,149  0,029  AMP-activated protein kinase stimulant
0,211  0,094  Platelet antagonist
0,167  0,050  Alkaline phosphatase inhibitor
0,220  0,103  Interleukin agonist
0,202  0,085  Nitric-oxide synthase stimulant
0,249  0,133  CYP3A4 substrate
0,126  0,009  Ca(v)3.1 blocker
0,133  0,017  Glutamate decarboxylase inhibitor
0,221  0,105  Flavin-containing monooxygenase substrate
0,175  0,060  Death-associated protein kinase 2 inhibitor
0,150  0,035  Xanthine oxidase inhibitor
0,135  0,020  Estrogen receptor beta antagonist
0,171  0,056  Antidote
0,119  0,005  Squalene synthetase inhibitor
0,127  0,013  HIV-1 integrase inhibitor
0,126  0,014  Leukotriene antagonist
0,152  0,040  Growth stimulant
0,134  0,023  Antibiotic
0,127  0,016  Beta tubulin antagonist
0,155  0,045  Pregnane X receptor agonist
0,188  0,078  Sedative
0,187  0,078  VEGF expression inhibitor
0,228  0,119  Insulysin inhibitor
0,142  0,035  GABA C receptor antagonist
0,144  0,036  Butyrylcholinesterase inhibitor
0,167  0,060  Hexokinase inhibitor
0,157  0,052  Carcinogenic, group 3
0,131  0,027  Actinic keratosis treatment
0,119  0,017  Na+ K+ transporting ATPase inhibitor
0,206  0,105  Antiviral (West Nile virus)
0,158  0,058  Hemostatic
0,180  0,080  DNA methyltransferase I inhibitor
0,135  0,036  Antifungal (Pneumocystis)
0,113  0,014  Alpha tubulin antagonist
0,139  0,041  MAO B inhibitor
0,281  0,184  Alzheimer's disease treatment
0,099  0,005  Squalene epoxidase inhibitor
0,145  0,052  Antihyperlipoproteinemic
0,131  0,038  Multidrug resistance-associated protein 1 inhibitor
0,127  0,034  GABA C receptor rho-1 antagonist
0,125  0,035  Antiviral (SARS coronavirus)
0,125  0,035  Antiviral (Coronavirus)
0,151  0,061  Histone deacetylase SIRT1 inhibitor
0,126  0,037  Sphingomyelinase inhibitor
0,129  0,040  Bronchodilator
0,145  0,058  Alpha-N-acetylglucosaminidase inhibitor
0,158  0,071  Carcinogenic, group 1
0,189  0,103  Cyclic AMP phosphodiesterase inhibitor
0,176  0,091  Antiviral (Influenza)
0,209  0,125  Antidiabetic (type 2)
0,094  0,010  Topoisomerase II beta inhibitor
0,130  0,046  Mucolytic
0,116  0,033  SULT1E1 substrate
0,130  0,049  Antiviral (Influenza B)
0,107  0,027  Glycine receptor antagonist
0,093  0,014  Heat shock protein 90 beta antagonist
0,107  0,028  Myeloperoxidase inhibitor
0,173  0,098  DNA methylase inhibitor
0,132  0,058  Gastritis treatment
0,086  0,016  Fatty acid synthase inhibitor
0,116  0,046  Dementia treatment
0,079  0,011  Dihydroorotate oxidase inhibitor
0,115  0,048  Carbonic anhydrase III inhibitor
0,123  0,055  Transcription factor STAT6 inhibitor
0,096  0,029  Prostaglandin-E synthase inhibitor
0,072  0,004  ATP citrate lysase inhibitor
0,096  0,029  Estrogen-related receptor beta agonist
0,112  0,046  Vascular dementia treatment
0,090  0,024  Antitreponemal
0,103  0,038  Interleukin 5 antagonist
0,132  0,067  Antihelmintic (Trematoda)
0,098  0,033  Histidine decarboxylase inhibitor
0,094  0,030  Narcotic antagonist
0,113  0,050  GST T1-1 substrate
0,085  0,022  Neuraminidase inhibitor
0,100  0,038  Glutathione S-transferase inhibitor
0,084  0,022  Aldose reductase inhibitor
0,073  0,012  Vanilloid 2 antagonist
0,095  0,033  Glutamate dehydrogenase inhibitor
0,078  0,017  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,083  0,022  Estrogen agonist
0,116  0,056  Ferrochelatase inhibitor
0,099  0,039  Antiviral (Trachoma)
0,088  0,030  Glycine receptor agonist
0,110  0,053  Gastric antisecretory
0,081  0,024  Maillard reaction inhibitor
0,074  0,018  Leukotriene B4 antagonist
0,116  0,060  Aldehyde dehydrogenase substrate
0,137  0,081  Cyclooxygenase inhibitor
0,103  0,047  Antifungal (Candida)
0,082  0,028  Endocannabinoid uptake inhibitor
0,153  0,101  Phospholipase C inhibitor
0,082  0,030  Peroxisome proliferator-activated receptor gamma antagonist
0,085  0,034  Phenylalanine 4-hydroxylase inhibitor
0,106  0,055  UDP-glucose 4-epimerase inhibitor
0,078  0,028  SULT2A1 substrate
0,075  0,024  Postmenopausal disorders treatment
0,076  0,026  Alcohol oxidase inhibitor
0,136  0,087  Antiviral (Influenza A)
0,137  0,088  Cholinergic
0,084  0,035  Phosphodiesterase VI inhibitor
0,090  0,042  CYP2A6 inhibitor
0,076  0,028  Neuraminidase (influenza) inhibitor
0,066  0,019  Leukotriene C antagonist
0,115  0,069  Cell adhesion inhibitor
0,107  0,061  Expectorant
0,065  0,020  Pregnane X receptor antagonist
0,108  0,064  Antihelmintic (Fasciola)
0,103  0,060  Chronic obstructive bronchitis treatment
0,064  0,020  Glucose-6-phosphate translocase inhibitor
0,057  0,014  Liver X receptor alpha agonist
0,122  0,081  Antineoplastic (uterine cancer)
0,095  0,054  Triose-phosphate isomerase inhibitor
0,104  0,063  Urease inhibitor
0,053  0,012  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,092  0,053  ATPase (Vacuolar H+) inhibitor
0,056  0,017  Geranyltranstransferase inhibitor
0,053  0,015  Dopamine D5 agonist
0,151  0,114  Phobic disorders treatment
0,128  0,092  Corneal wound healing stimulator
0,091  0,055  Antidote, mercury
0,078  0,043  Phosphofructokinase-1 inhibitor
0,083  0,048  Carbonic anhydrase XIII inhibitor
0,149  0,115  Anesthetic general
0,180  0,146  Huntington's disease treatment
0,049  0,015  Kainate receptor agonist
0,123  0,090  Hair growth stimulant
0,094  0,061  Antineoplastic, alkylator
0,070  0,037  Protease 3C (Human rhinovirus) inhibitor
0,093  0,060  Falcipain inhibitor
0,066  0,034  Xanthine dehydrogenase inhibitor
0,042  0,010  Leukotriene B4 receptor 1 antagonist
0,091  0,059  Falcipain 2 inhibitor
0,095  0,063  Interleukin 12 antagonist
0,067  0,036  Transcription factor RelA inhibitor
0,102  0,071  Choleretic
0,100  0,070  Toll-Like receptor 4 antagonist
0,084  0,055  Inducible nitric-oxide synthase inhibitor
0,083  0,054  Carbonic anhydrase VI inhibitor
0,061  0,032  Postcoital contraceptive
0,134  0,105  Aldose reductase substrate
0,034  0,006  Vanilloid 2 agonist
0,147  0,119  Psychostimulant
0,143  0,115  ATPase inhibitor
0,157  0,130  Histone acetyltransferase inhibitor
0,058  0,031  Cannabinoid CB2 receptor antagonist
0,034  0,007  Leukotriene B4 receptor 2 antagonist
0,034  0,007  Prostaglandin F2 alpha agonist
0,043  0,017  Leukotriene C4 antagonist
0,045  0,019  Estrogen receptor alpha agonist
0,117  0,092  Antiprotozoal (Trichomonas)
0,061  0,037  Sphingosine kinase inhibitor
0,039  0,014  Prostaglandin agonist
0,145  0,122  Interleukin antagonist
0,096  0,073  Adenylate kinase inhibitor
0,041  0,019  Retinoid X alpha receptor agonist
0,052  0,031  Peroxisome proliferator-activated receptor alpha agonist
0,041  0,020  Nicotinic acid receptor agonist
0,195  0,175  Angiogenesis inhibitor
0,040  0,020  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,045  0,025  DNA gyrase subunit A inhibitor
0,031  0,012  Protein 30S ribosomal subunit inhibitor
0,055  0,036  Thromboxane synthase inhibitor
0,037  0,019  HMG CoA reductase inhibitor
0,061  0,043  Heme oxygenase stimulant
0,021  0,004  Antibiotic Tetracycline-like
0,059  0,042  Androgen agonist
0,060  0,043  Antidote, heavy metal
0,060  0,044  Purinergic P2X1 antagonist
0,089  0,073  Antithrombocytopenic
0,048  0,033  Glucose-6-phosphate isomerase inhibitor
0,039  0,025  Retinoid X receptor antagonist
0,083  0,069  NADH dehydrogenase inhibitor
0,123  0,110  Thiol protease inhibitor
0,081  0,067  Transcription factor NF kappa B stimulant
0,035  0,023  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,068  0,056  Aminopeptidase I inhibitor
0,040  0,029  Cholesterol absorption inhibitor
0,034  0,024  Fumarate hydratase inhibitor
0,035  0,025  Retinoid X receptor agonist
0,022  0,012  Neuraminidase (Influenza B) inhibitor
0,140  0,130  Neurotensin receptor agonist
0,027  0,017  Thyroid hormone agonist
0,039  0,030  VCAM-1 antagonist
0,039  0,030  VCAM antagonist
0,019  0,012  Antibiotic Anthracycline-like
0,055  0,048  Lipocortins synthesis agonist
0,136  0,129  Pyruvate kinase inhibitor
0,039  0,032  Estradiol 17 beta-dehydrogenase inhibitor
0,090  0,083  Carbonic anhydrase XV inhibitor
0,066  0,060  Histone deacetylase SIRT1 stimulant
0,066  0,060  Histone deacetylase stimulant
0,031  0,025  Catechol O-methyltransferase inhibitor
0,123  0,117  Sphingosine 1-phosphate receptor 5 antagonist
0,171  0,165  Amyotrophic lateral sclerosis treatment
0,081  0,076  Aminoacyl-tRNA synthetase inhibitor
0,197  0,194  Interleukin 2 agonist
0,070  0,067  GABA B receptor agonist
0,061  0,058  Sirtuin 1 inhibitor
0,052  0,049  Prostaglandin EP2 antagonist
0,046  0,045  Aconitate hydratase inhibitor
0,104  0,103  Retinoprotector
0,046  0,046  Thromboxane antagonist
0,126  0,125  Diabetic retinopathy treatment
0,021  0,020  Prostaglandin E2 agonist
0,067  0,067  GABA aminotransferase inhibitor
0,021  0,020  Retinoic acid receptor agonist
0,122  0,122  Antifungal (Cryptococcus)

